Chiesi Ventures Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
1
- Investments
-
16
- Portfolio
-
3
- Exits
-
7
Chiesi Ventures General Information
Company Description
Founded in 2014, Chiesi Ventures is the corporate venture capital arm of Chiesi Farmaceutici based in Boston, Massachusetts. The firm prefers to invest in seed, start-ups, and early-stage firms operating in the healthcare, life sciences, biological entity, pharmaceutical product, disease discovery, diagnosis, and health technology sectors.
Business Details
Website
www.chiesiventures.comYear Founded
Investor Status
Primary Investor Type
Corporate Office
- One Boston Place
- Suite 4000
- Boston, MA 02109
- United States
Chiesi Ventures Investments (16)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Glycomine | 14-May-2026 | Later Stage VC | Drug Discovery | Clinical Trials - Phase 2 | ||
| Glycomine | 11-Jun-2021 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Aura Biosciences | 22-Mar-2021 | Drug Discovery | Generating Revenue/Not Profitable | |||
| 4D Molecular Therapeutics | 16-Jun-2020 | Drug Discovery | Generating Revenue | |||
| Minoryx | 20-May-2020 | Drug Discovery | Generating Revenue | |||
| VelosBio | 08-May-2020 | Pharmaceuticals | Generating Revenue | |||
| Reneo Pharmaceuticals | 09-May-2019 | Drug Discovery | Generating Revenue | |||
| Mirum Pharmaceuticals | 12-Apr-2019 | Pharmaceuticals | Generating Revenue | |||
| Aura Biosciences | 13-Dec-2018 | Later Stage VC | Drug Discovery | Generating Revenue/Not Profitable | ||
| CuraSen | 17-Oct-2018 | Later Stage VC | Drug Discovery | Clinical Trials - Phase 2 |
Chiesi Ventures Exits (7)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Sentien (Drug Discovery) | 29-Sep-2025 | Out of Business | |
| Aura Biosciences | 02-Nov-2021 | ||
| Reneo Pharmaceuticals | 09-Apr-2021 | ||
| VelosBio | 18-Dec-2020 | ||
| 4D Molecular Therapeutics | 11-Dec-2020 | ||
| Mirum Pharmaceuticals | 18-Jul-2019 | IPO | |
| Kezar Life Sciences | 21-Jun-2018 | IPO |
Chiesi Ventures Investments by Industry, Year, and Region
Chiesi Ventures Co-Investors (11)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Abingworth | 1 |
|
|
||
| CTI Life Sciences Fund |
|
|
|||
| Novo Holdings |
|
|
|||
| RiverVest Venture Partners |
|
|
|||
| Sanderling Ventures |
|
|
Chiesi Ventures FAQs
-
What is Chiesi Ventures?
Founded in 2014, Chiesi Ventures is the corporate venture capital arm of Chiesi Farmaceutici based in Boston, Massachusetts.
-
When was Chiesi Ventures founded?
Chiesi Ventures was founded in 2014.
-
Where is Chiesi Ventures headquartered?
Chiesi Ventures is headquartered in Boston, MA.
-
How many investments has Chiesi Ventures made?
Chiesi Ventures has made 16 investments.
-
What has Chiesi Ventures invested in?
Chiesi Ventures has made numerous investments in companies like Glycomine, Aura Biosciences, and 4D Molecular Therapeutics within the Drug Discovery industry.
-
What has Chiesi Ventures invested in recently?
Chiesi Ventures's latest investment was on 14-May-2026 in Glycomine, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process